News

MuGard forms a protective coating over the oral mucosa when swirled gently around the mouth. In a comparison of cancer patients receiving standard mucositis care with those patients

The trial was a double-blind, randomized, active comparator study of LT-NS001 (formerly MX-1094) vs. naproxen in patients aged 45 to 70 years. In the trial, the patients underwent

The amendment contains testing results to establish self-life of the product. FDA has requested no additional clinical trial for Stelara Earlier in June 2008, FDA’s Dermatologic and Ophthalmic

Recombineering with Red/ET will allow cloning, subcloning, and modification of DNA at any chosen position. It permits precise engineering of DNA molecules of any size, including large one

KineMed’s stable isotope technology is a translational and personalized medicine platform to identify and characterize novel biomarkers in cerebrospinal fluid to facilitate development of new drugs for the

Also, CTI was ordered to immediately pay an additional $776,454 to Spectrum by wire transfer. Raj Shrotriya, MD, Chairman, CEO and President of Spectrum Pharmaceuticals, said: “we are

Besides Congress, AdvaMed lobbied the Department of Health and Human Services and the FDA in the January-March 2009 period, according to a form filed April 20, 2009 with

The Phase 3 clinical trial (PHIRST-1) randomized, double-blind, 16-week placebo-controlled of Adcirca for PAH, patients taking Adcirca 40 mg (administered as two 20 mg tablets) once daily, achieved

Presently, researchers use DNA sequencing as a method for identifying genetic variation. Scientists participating in an early evaluation of the technology are interested in studying the most widely